ATRC (AtriCure) Shiller PE Ratio: (As of Sep. 08, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ATRC AtriCure Inc ATRC
79 GF Score
Price $52.91
GF Value $39.74
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is AtriCure Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


AtriCure  (NAS:ATRC) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


AtriCure Shiller PE Ratio Related Terms


AtriCure Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for AtriCure's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AtriCure Shiller PE Ratio Chart

AtriCure Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

AtriCure Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ATRC vs XRAY, WRBY, LMAT: Shiller PE Ratio Comparison

For the Medical Instruments & Supplies subindustry, AtriCure's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AtriCure Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AtriCure's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where AtriCure's Shiller PE Ratio falls into.


ATRC
79GF Score
AtriCure Inc ATRC
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AtriCure Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

AtriCure's E10 for the quarter that ended in Jun. 2026 is calculated as:

For example, AtriCure's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.18/333.9520*333.9520
=0.180

Current CPI (Jun. 2026) = 333.9520.

AtriCure Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201609 -0.210 241.428 -0.290
201612 -0.270 241.432 -0.373
201703 -0.320 243.801 -0.438
201706 -0.210 244.955 -0.286
201709 -0.220 246.819 -0.298
201712 -0.080 246.524 -0.108
201803 -0.310 249.554 -0.415
201806 -0.010 251.989 -0.013
201809 -0.220 252.439 -0.291
201812 -0.090 251.233 -0.120
201903 -0.150 254.202 -0.197
201906 -0.110 256.143 -0.143
201909 -0.250 256.759 -0.325
201912 -0.420 256.974 -0.546
202003 -0.420 258.115 -0.543
202006 -0.200 257.797 -0.259
202009 -0.110 260.280 -0.141
202012 -0.420 260.474 -0.538
202103 -0.380 264.877 -0.479
202106 -0.360 271.696 -0.442
202109 2.110 274.310 2.569
202112 -0.300 278.802 -0.359
202203 -0.330 287.504 -0.383
202206 -0.320 296.311 -0.361
202209 -0.270 296.808 -0.304
202212 -0.090 296.797 -0.101
202303 -0.140 301.836 -0.155
202306 -0.110 305.109 -0.120
202309 -0.200 307.789 -0.217
202312 -0.210 306.746 -0.229
202403 -0.280 312.332 -0.299
202406 -0.170 314.175 -0.181
202409 -0.170 315.301 -0.180
202412 -0.330 315.605 -0.349
202503 -0.140 319.799 -0.146
202506 -0.130 322.561 -0.135
202509 -0.010 324.800 -0.010
202512 0.040 324.054 0.041
202603 0.000 330.213 0.000
202606 0.180 333.952 0.180

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is AtriCure (ATRC) Overvalued in 2026?

Based on GuruFocus' analysis, AtriCure stock appears to be overvalued. The current stock price of $52.91 is trading 33.1% above its estimated GF Value™ of $39.74. GuruFocus considers AtriCure to be Significantly Overvalued.

Key valuation signals for ATRC:

  • Shiller PE Ratio:
  • GF Value™: $39.74 vs. price of $52.91 (33.1% above fair value)
  • GF Score™: 79/100 with 6 warning signs

No single metric tells the full story. See the ATRC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AtriCure Business Description

Other Exchanges A5I:Germany
Address 7555 Innovation Way, Mason, OH, USA, 45040
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
79GF Score

Get the complete analysis for ATRC

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$52.91
Price
$39.74
GF Value